ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC

NCT06351332 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Cancer Female
Triple Negative Breast Cancer
Hormone Receptor Negative Malignant Tumor Breast Triple
HER2-negative Breast Cancer

Interventions

DRUG: Azenosertib
DRUG: Carboplatin
DRUG: Pembrolizumab

Sponsor

Filipa Lynce, MD

Collaborators

[object Object]
[object Object]